logo
Select company
Select metric
53.25%Cash to Assets Ratio
VS
Market
92
Sector
75
Industry
65
History
81
$ 3.33Close
$ 3.31 - $ 570.6 52-Week Range
Ticker Information

Ticker

CERO

Company Name

CERO THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERO THERAPEUTICS HOLDINGS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CERO - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 6.2M$ 3.3M53.25%
3/31/2025$ 7.99M$ 5.2M65.11%
12/31/2024$ 6.21M$ 3.33M53.6%
9/30/2024$ 6.49M$ 3.38M52.07%
6/30/2024$ 7.37M$ 3.65M49.48%
3/31/2024$ 9.05M$ 4.59M50.74%
12/31/2023$ 8.56M$ 96.87K1.13%
9/30/2023$ 8.47M$ 119.01K1.41%
6/30/2023$ 14.11M$ 105.23K0.75%
3/31/2023$ 14.43M$ 178.09K1.23%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CERO THERAPEUTICS HOLDINGS INC is calculated as follows: CashnEq [ $ 0 ] / Assets [ $ 25K ]
(=) Cash to Assets [ 0% ]

CERO - Cash to Assets Ratio, Last 5 years

0%

Minimum

Jun 30, 2021

99.47%

Maximum

Dec 31, 2022

25.29%

Average

1.23%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%